vimarsana.com

Page 6 - ஹைதராபாத் அடிப்படையிலானது பாரத் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Karnataka Govt Places Order For 1 Crore Doses Of Covid-19 Vaccine To Inoculate Adults In 18-44 Age Group

Karnataka Govt Places Order For 1 Crore Doses Of Covid-19 Vaccine To Inoculate Adults In 18-44 Age Group by IANS - Apr 29, 2021 03:19 AM Karnataka Chief Minister B S Yediyurappa Karnataka on Wednesday (28 April) placed an order to buy 1 crore doses of anti-Covid vaccines to inoculate adults in the 18-44 years age group free from next month. As the third phase of anti-Covid vaccination drive will roll out from 1 May for the 18-44 years age group, the state government has placed an order to purchase 1 crore doses, according to an official statement. Though the order did not mention vaccine names, an official told IANS that the state would buy Covishield from the Pune-based Serum Institute of India and Covaxin from the Hyderabad-based Bharat Biotech.

Karnataka buying 1 cr doses to vaccinate 18-44 age group

Karnataka buying 1 cr doses to vaccinate 18-44 age group ​ By IANS | Published on ​ Wed, Apr 28 2021 23:51 IST | ​ 13 Views B.S. Yediyurappa.. Image Source: IANS News Bengaluru, April 28 : Karnataka on Wednesday placed an order to buy 1 crore doses of anti-Covid vaccines to inoculate adults in the 18-44 years age group free from next month. As the third phase of anti-Covid vaccination drive will roll out from May 1 for the 18-44 years age group, the state government has placed an order to purchase 1 crore doses, according to an official statement here. Though the order did not mention vaccine names, an official told IANS that the state would buy Covishield from the Pune-based Serum Institute of India and Covaxin from the Hyderabad-based Bharat Biotech.

Maharashtra: Serum Institute can supply Covishield only after May 20, says Rajesh Tope

Public Health Secretary Dr Pradeep Vyas, in a letter dated April 26 to SII, had asked the company how many Covishield doses it would be able to supply to Maharashtra every month for a six-month period beginning May 2021. He had also asked what will be the procurement price per dose and other conditions, if any. ‘’The Government of India has announced a National COVID-19 vaccination strategy which will be in effect from May 1. If the Government of Maharashtra decides to vaccinate the 18 to 44 years age group, then about 12 crore vaccine doses would be required. In this context, we would like you to inform us as to how many doses of Covishield you would be able to supply to the Government of Maharashtra every month for the next six months period beginning May, 2021,’’ said Dr Vyas. The state government has dashed off a similar letter to Hyderabad-based Bharat Biotech.

State to buy one crore doses of vaccine

State to buy one crore doses of vaccine Updated: Updated: ₹483 crore needed for vaccine purchase, Cabinet against lockdown in State Share Article ₹483 crore needed for vaccine purchase, Cabinet against lockdown in State The State will purchase one-crore doses of COVID-19 vaccines directly from two manufacturers to make it available for those in the 18-45 age group. A Cabinet meeting chaired by Chief Minister Pinarayi Vijayan here on Wednesday took the decision hours before the online registration for those in the 18-45 age group began. The vaccines will cost the State ₹483 crore. Of the one-crore doses, 70 lakh doses will be Covishield from the Pune-based Serum Institute of India and the remaining Covaxin from the Hyderabad-based Bharat Biotech. The first 10-lakh doses will be purchased next week and the entire purchase will be completed by July.

India s pharma sector needs a shot in the arm to fight the pandemic

SHARE As India grapples with a massive second wave of coronavirus infections, the country’s pharmaceutical industry is under pressure to deliver vaccines and medicines. Dubbed the ‘pharmacy of the world’, India’s sprawling pharmaceutical factories were expected to supply the bulk of Covid-19 vaccines and medicines to the world. But a record jump in coronavirus cases in a country of more than 1.3 billion people is putting the sector under strain. India’s health ministry on Saturday reported another 346,786 new Covid-19 infections. “The pharmaceutical industry does need to ramp up its infrastructure to facilitate higher production of essential [drugs and vaccines],” says Dr Nikhil Mathur, the chief of medical services at Care Group of Hospitals.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.